ddjd

Member
Joined
Jul 13, 2014
Messages
6,722
As another forum member noted, it sounds like serotonin symptoms. Never heard or seen studies of emodin/cascara producing such effects. But of course it is good to always be mindful of side effects.

 

ddjd

Member
Joined
Jul 13, 2014
Messages
6,722
No, I have not seen anything indicating that the lapachones would have the same effect on colon. Also, if you take it topically cascara won't have the colon-darkening effects it exhibits when taken orally.
How do you take cascara topically?
 
OP
haidut

haidut

Member
Forum Supporter
Joined
Mar 18, 2013
Messages
19,799
Location
USA / Europe

The study did not use emodin, it used cascara bark, which contains numerous other substances in addition to emodin. Emodin itself has been shown to inhibit iNOS.

Also, the study says the used dexamethasone as a NO inhibitor, which is quite strange since even if that steroid inhibits NO synthesis/release it has a number of other pro-constipation properties (e.g. activation of GR receptor and raising prolactin) so the claim that its usage demonstrates the role of NO in cascara's effects cannot be taken seriously. There is a highly selective NO inhibitor known as L-NAME and it is the drug of choice for most studies trying to study/manipulate the NO pathway. Why they chose to not use L-NAME but went for a steroid with a myriad of other effects is beyond me...
 

ddjd

Member
Joined
Jul 13, 2014
Messages
6,722
The study did not use emodin, it used cascara bark, which contains numerous other substances in addition to emodin. Emodin itself has been shown to inhibit iNOS.

Also, the study says the used dexamethasone as a NO inhibitor, which is quite strange since even if that steroid inhibits NO synthesis/release it has a number of other pro-constipation properties (e.g. activation of GR receptor and raising prolactin) so the claim that its usage demonstrates the role of NO in cascara's effects cannot be taken seriously. There is a highly selective NO inhibitor known as L-NAME and it is the drug of choice for most studies trying to study/manipulate the NO pathway. Why they chose to not use L-NAME but went for a steroid with a myriad of other effects is beyond me...
Appreciate this reply, many thanks!
 

Mauritio

Member
Joined
Feb 26, 2018
Messages
5,669
Emodin's effect seem to rely on activating the FXR (Farnesoid X Receptor) because "...it did not improve lipid accumulation, insulin sensitivity, or glucose tolerance in HFD-fed FXR knockout mice."
- Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway - PubMed

The "X"-receptor type family is quite interesting, including FXR, PXR and RXR. They have numerous benefits as seen in the study above: emodin was basically useless, witout it beeing able to activate the FXR.

Here is some more info on the FXR:

- Activating FXR decreases PUFA in the liver

- Is it Crazy to take Ivermectin Every Day?
 
Last edited:
EMF Mitigation - Flush Niacin - Big 5 Minerals
Back
Top Bottom